Proteomic Strategies for Individualizing Therapy of Acute MyeloidLeukemia (AML)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|7|3|159-170

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.7, Iss.3, 2006-06, pp. : 159-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimizing Therapy for Acute Myeloid Leukemia

By Kohrt Holbrook E.   Coutre Steven E.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 10, 2008-11 ,pp. : 1003-1016

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

New Developments of Differentiation Therapy of Acute Myeloid Leukemia

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 14, Iss. 2, 2017-04 ,pp. : 86-105

Bentham Science Publishers

Access to resources Recommend Favorite

Development of personalized molecular therapy for acute myeloid leukemia

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 1, 2016-01 ,pp. : 20-29

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Therapeutic Approaches for the Treatment of Acute Myeloid Leukemia with AML1-ETO Translocation

By  

Current Cancer Drug Targets, Vol. 16, Iss. 3, 2016-03 ,pp. : 215-225

Bentham Science Publishers

Access to resources Recommend Favorite

Acute Myeloid Leukemia

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 10, 2008-11 ,pp. : 962-962

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite